Start a live chat
1-800-870-4800
The oldest people alive
are not outliers —
they are a different biological profile.
When researchers study supercentenarians — people who have lived past 110 — they do not find bodies that have simply aged more slowly across the board. They find bodies with a distinct cellular signature: immune systems that have remodeled differently, inflammatory profiles that diverge from the population, and molecular patterns that suggest the oldest old are not just lucky. They are biologically distinguishable. Understanding what distinguishes them is where longevity biology becomes most specific.
I
What the oldest humans
have in cellular common.
The study of centenarians — and the smaller subset of supercentenarians who reach 110 and beyond — has become one of the most informative frontiers in longevity biology. Not because extreme longevity is the primary goal of the research, but because the oldest old represent a natural experiment: individuals who have navigated the accumulated cellular challenges of a century of aging and arrived at the far end in a measurably different state than those who did not. Their biology is not a model of absence — of simply having fewer age-related changes. It is a model of a different trajectory.
The most consistent finding across studies of supercentenarians is the state of their immune systems. The immune aging process — immunosenescence — follows a predictable trajectory in most people: the naive T cell pool shrinks, terminally exhausted memory T cells accumulate, and the chronic low-grade inflammatory tone of inflammaging rises through the seventh and eighth decades of life. In people who reach 110 and beyond, this trajectory does not appear simply slowed. It appears altered. The ratio of immune cell populations, the inflammatory cytokine profiles, and the NAD+-degrading CD38 activity of their immune cells have been characterized in multiple studies as distinguishable from age-matched peers who did not survive to supercentenarian age.
What this suggests — carefully, without overstating the evidence — is that extreme longevity is not primarily a matter of avoiding the stresses that drive cellular aging. It may be a matter of how the body responds to those stresses at the molecular level: specifically, how efficiently the cellular maintenance systems that NAD+ supports, the inflammatory regulatory systems that the immune aging clock governs, and the epigenetic regulation systems that the epigenome coordinates, are maintained across a century of cellular challenge.
The oldest old do not simply
have fewer age-related changes.
They have a different trajectory —
a cellular signature
that diverges from the population
long before extreme age is reached.
The Immune Aging Trajectory
How the immune system changes
across the decades — and where the oldest old diverge.
Broad naive T cell repertoire — maximal capacity for novelty response
The naive T cell pool — the immune system's capacity to respond to pathogens it has not previously encountered — is at its broadest in early adulthood. Thymic output, while declining from its childhood peak, remains sufficient to maintain a diverse T cell receptor repertoire. Inflammatory tone is low; the balance between pro-inflammatory and regulatory immune populations favors rapid response followed by clean resolution. The NAD+ pool is typically well-maintained, with NAMPT activity sufficient to sustain the Salvage Pathway and the sirtuin-mediated regulation of immune gene expression that SIRT1 and SIRT6 coordinate.
In supercentenarian studies, the immune genetics and inflammatory set points of the oldest old may already diverge from the general population at this life stage.
Memory T cell accumulation begins — inflammaging establishes its first measurable signals
The ratio of naive to memory T cells shifts substantially through midlife as the thymus continues involuting and the immune system increasingly relies on the memory populations established by prior exposures. A subset of highly differentiated, terminally exhausted memory T cells begins to accumulate — metabolically active, producing inflammatory cytokines, and resistant to apoptosis. Circulating markers of low-grade inflammation — IL-6, CRP, TNF-α — begin a gradual rise. CD38 expression on immune cells, driven by NF-κB-mediated inflammatory signaling, rises with this inflammatory activation, contributing to the progressive decline in the NAD+ pool that characterizes aging tissue.
Studies examining the offspring of centenarians at this life stage find measurably lower inflammatory markers and more favorable immune cell compositions — suggesting the divergence from typical aging trajectories begins decades before extreme longevity is achieved.
The population diverges — those on a centenarian trajectory show a distinct immune remodeling pattern
By the eighth decade, the immunosenescent profile is established in most people: elevated inflammatory cytokines, a narrowed T cell repertoire, elevated CD38 activity, and a NAD+ pool under compound pressure from both the NAMPT decline of general aging and the CD38-mediated degradation of inflammaging. In studies comparing individuals who go on to reach 100 or beyond with those who do not, the differences in immune profiles at this stage are measurable and statistically distinguishable. The centenarian-trajectory individuals tend to show lower levels of pro-inflammatory cytokines, more favorable CD4/CD8 T cell ratios, and immune cell compositions that suggest better-preserved regulatory capacity.
The biology of this divergence is not fully understood. Current research associates it with genetic variants in immune regulation genes, differential expression of anti-inflammatory pathways, and features of NAD+ metabolism and mitochondrial function.
A distinct cellular signature — not simply less aging, but differently aged
At 100 and beyond, the cellular biology of centenarians diverges most starkly from age-matched peers who did not survive to this age. Rather than the extreme exhaustion of the immune system that might be expected from a century of antigenic challenge, many centenarians show a distinct immune profile: a preserved, if altered, balance of immune populations; lower levels of the most damaging pro-inflammatory cytokines; and, in some cases, evidence of what researchers describe as "inflammaging deceleration" — a point at which the rising inflammatory trajectory of typical aging appears to plateau or slow. Studies examining telomere dynamics, epigenetic age measures, and mitochondrial function in centenarians consistently find evidence not of uniformly slow aging but of a cellular architecture that has maintained its key systems more effectively across time.
Studies referenced here were conducted independently and did not involve any specific Codeage product.
II
What distinguishes the biology —
inflammation, NAD+, and the molecular signature of longevity.
The cellular biology that distinguishes centenarians from those who do not reach extreme old age is not a single molecule or a single pathway. It is a pattern of interaction among systems that together determine how the body maintains cellular integrity across a century of metabolic stress, immune challenge, and the accumulated molecular damage that aging produces. But within that pattern, several molecular features appear consistently enough across centenarian studies to merit specific attention.
The most replicated finding is the inflammatory profile. Centenarians, as a group, show lower circulating levels of pro-inflammatory cytokines — particularly IL-6 and TNF-α, two of the cytokines most consistently associated with accelerated biological aging and elevated mortality risk in older populations. This is not an absence of inflammation — centenarians have experienced a century of immune activation, infection, and the chronic inflammatory signal of aging tissue. But the regulatory systems that modulate inflammatory tone appear to have maintained greater functional capacity in those who reach extreme old age. The sirtuin pathway — whose SIRT1 and SIRT6 members directly regulate NF-κB-driven inflammatory gene expression in an NAD+-dependent manner — is among the molecular systems implicated in this differential inflammatory regulation.
A second consistent finding concerns NAD+ metabolism itself. Studies examining NAD+ levels and related metabolites in centenarians and near-centenarians have found evidence that the NAD+ pool in the oldest old is maintained at relatively higher levels than in age-matched non-survivors, and that the activity of CD38 — the primary NAD+-degrading enzyme whose age-related rise is driven by chronic inflammatory NF-κB signaling — may be differentially regulated in the centenarian immune profile. The causal direction of this relationship is not established — whether better-maintained NAD+ biology contributes to the centenarian trajectory, or whether the centenarian trajectory produces better-maintained NAD+ biology as a consequence — is an active area of research. The association is real; the mechanism is still being characterized. The biology of longevity, immune aging, NAD+ metabolism, and their interactions in the oldest old represents one of the most active and consequential research frontiers in aging science today.
Molecular Features of Extreme Longevity
Four cellular features found more consistently
in centenarian studies than in typical aging populations.
These are documented associations in the centenarian research literature — not claims about causation or outcomes. All studies referenced were conducted independently and did not involve any specific Codeage product.
Lower chronic inflammatory tone — with preserved acute response capacity
Centenarian studies consistently find lower circulating levels of pro-inflammatory cytokines — particularly IL-6, TNF-α, and CRP — compared to populations of similar age who do not reach extreme old age. This lower chronic inflammatory tone is not accompanied by a corresponding reduction in acute inflammatory response capacity — suggesting the oldest old have maintained a more precise regulatory calibration of inflammatory signaling rather than simply a globally reduced immune activity. The NF-κB-SIRT1-SIRT6 regulatory axis — which modulates inflammatory gene expression in an NAD+-dependent manner — is one of the molecular candidates for this differential calibration.
Association replicated across Italian, Japanese, and European centenarian cohort studies.
Relatively preserved NAD+ pools and differential CD38 activity in immune cells
Several studies examining NAD+ metabolomics in centenarian and near-centenarian populations have found evidence of relatively better-maintained NAD+ levels compared to age-matched non-survivors, with some evidence of differential CD38 expression in immune cell populations. CD38 — the primary NAD+-degrading enzyme on immune cells — is upregulated by NF-κB-driven inflammatory signaling; the lower chronic inflammatory tone of centenarians may therefore contribute to relatively lower CD38-mediated NAD+ consumption, creating a compounding relationship between the inflammatory and metabolic features of the centenarian cellular profile.
Active research area; causal relationships not established. Studies were independent and did not involve any specific Codeage product.
Not longer telomeres — but a different rate of telomere attrition across the lifespan
Centenarians do not typically have the long telomeres of young people — a century of cell divisions and oxidative stress has produced the telomere shortening expected of extreme age. What distinguishes the oldest old in telomere research is not the absolute length at extreme age but the trajectory: evidence from longitudinal studies and offspring studies suggests those on a centenarian trajectory may experience slower age-related telomere attrition across the middle decades of life. SIRT6's documented role in telomeric chromatin maintenance — an NAD+-dependent function — is among the molecular pathways potentially relevant to this differential attrition rate.
Telomere findings vary across centenarian cohorts; population heterogeneity is significant.
Epigenetic clocks consistently show decelerated biological aging in the oldest old
Studies applying epigenetic clocks — DNA methylation-based biological age estimators — to centenarian populations consistently find that the oldest old show lower epigenetic age relative to their chronological age compared to the general population. The gap between epigenetic age and chronological age — sometimes called "epigenetic age deceleration" — is among the most robust molecular signatures differentiating centenarians from typical aging populations. The NAD+-dependent sirtuin histone deacetylases that govern epigenetic maintenance — SIRT1 and SIRT6 in particular — are among the molecular systems whose differential activity in centenarian biology is actively studied in this context.
Epigenetic clock findings in centenarians replicated in multiple independent cohort studies.
III
What the centenarian biology
tells us about the systems that matter most.
The study of supercentenarians and centenarians is not, ultimately, a study of extreme cases. It is a study of which biological systems, maintained most effectively across a human lifespan, produce the cellular architecture that aging appears least able to overwhelm. The consistent findings — lower inflammatory tone, relatively preserved NAD+ metabolism, differential epigenetic aging, better-maintained immune regulatory capacity — are not arbitrary. They map directly onto the molecular systems whose connections to longevity biology the broader aging research literature has characterized through independent routes: the sirtuin–NAD+ axis, the CD38–inflammaging feedback loop, the epigenetic maintenance systems whose NAD+ dependency the genome regulation articles in this series have covered in depth.
The convergence between what centenarian studies find in the oldest old and what mechanistic aging biology predicts should characterize successful aging is one of the more intellectually satisfying features of the current longevity research landscape. The systems that theory predicts should matter — inflammatory regulation, NAD+ maintenance, epigenetic fidelity, mitochondrial quality control — are the same systems that appear differentially maintained in the people who live longest. This convergence does not prove causation in either direction. But it provides a level of coherence across independent lines of evidence that the field has not always had, and that makes the mechanistic story of cellular longevity considerably more credible than it was a decade ago.
The biology of extreme longevity, immune aging, and the molecular signatures of the oldest old continues to be an active and rapidly developing research area. What is described here reflects the current state of a literature that will look considerably more complete — and more precise about mechanisms — in the years ahead. For the immune aging biology that underlies the centenarian immune profile, the immune aging article covers the full CD38–NAD+ connection. For the mitochondrial convergence of longevity pathways that frames the centenarian cellular context, the mitochondria longevity article covers the pathway architecture in full.
The systems that theory predicts
should matter in aging —
inflammatory regulation,
NAD+ maintenance, epigenetic fidelity —
are the same systems
found differentially maintained
in the people who live longest.
Codeage · Cellular Longevity · Pillar 03
Formulas for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension of the system built around NAD+ biology, mitochondrial health, and the molecular science of cellular aging.
Codeage Liposomal NMN Platinum+
Liposomal NMN formula with nicotinamide mononucleotide and complementary cellular longevity ingredients. Delivered via Helix Liposomal Technology. Formulated without dairy, soy, or gluten. Non-GMO. Manufactured in the USA in a cGMP-certified facility with global ingredients.
Join The Code →Codeage Liposomal NMN 1000 Powder
High-potency NMN powder formula with liposomal delivery. 1000mg NMN per serving with betaine and complementary cellular support ingredients. Formulated without dairy, soy, or gluten. Non-GMO. Manufactured in the USA in a cGMP-certified facility with global ingredients.
Join The Code →Previously in This Series
Mitochondria may be where longevity pathways either work — or don't.
Codeage · The Longevity Code
A system built for
the long view.
The Longevity Code is a four-pillar daily system — every formula mapped to a specific dimension of how the body sustains itself across time.
Explore The Longevity Code →
